$38.42
0.280.73%
At close: -
$40.00
1.584.11%
After Hours: Dec 24, 3:23 PM EDT
Xenon Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Xenon Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.81 | $-0.81 | 0.00 % |
Jun 2024 | 2024-08-08 | $-0.75 | $-0.70 | -7.14 % |
Mar 2024 | 2024-05-09 | $-0.62 | $-0.66 | 6.06 % |
Dec 2023 | 2024-02-29 | $-0.64 | $-0.76 | 15.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-02-29 | $0 | $1.89M | -100.0 % |
Sep 2023 | 2023-11-08 | $0 | $1.45M | -100.0 % |
Jun 2023 | 2023-08-09 | $0 | $400.00K | -100.0 % |
Mar 2023 | 2023-05-09 | $0 | $570.00K | -100.0 % |
Xenon Pharmaceuticals (XENE) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.81, which hit the estimate of $-0.81.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.